- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03546699
Hospital-wide Incidence, Clinical Characteristics and Outcomes of ARDS
A Multicenter Prospective Cohort Study of Hospital-wide Incidence, Clinical Characteristics and Outcomes of ARDS - The NITWA ARDS Study
The Acute Respiratory Distress Syndrome (ARDS) impacts one of every four patients requiring mechanical ventilation for respiratory support and carries a mortality rate of 40%. To diagnose ARDS, doctors currently use the Berlin definition, that requires chest radiographs and analysis of oxygenation in the blood (arterial blood gas). These tests are not available in areas of the world with constrained resources and may be unnecessarily invasive. A modification of the Berlin definition, using ultrasound and pulse oximetry (a small device that measures oxygen level non-invasively by clipping to the body, typically a finger), has been recently developed and tested in Kigali, Rwanda.
This study will try to confirm the validity of the Kigali modification initially in Boston and Toronto and subsequently in other hospitals worldwide. If confirmed, this new definition could allow for faster recognition and potentially improved treatment of patients with ARDS and facilitate studies worldwide.
The purposes of this study are:
- To describe clinical characteristics and outcomes of patients diagnosed with ARDS according to the Berlin and Kigali definitions;
- To determine how well chest radiograph and ultrasound of the chest are able to define ARDS, in comparison to chest computer tomography (CT).
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
We hypothesize that the hospital-wide incidence of ARDS, as defined by the Kigali modification, is similar in high resource settings (e.g., Boston and Toronto) as compared to the resource-constrained setting of Kigali, Rwanda. We also hypothesize that pulmonary ultrasound is a more sensitive and similarly specific imaging modality for bilateral opacities than chest radiograph, when compared to the reference standard of chest tomography.
We will test these hypotheses in a multicenter prospective cohort study with the following specific aims:
Aim 1: A) To estimate the hospital-wide incidence of ARDS defined according to both the Berlin definition and the Kigali modification, and B) To describe clinical characteristics and outcomes for these patients.
Aim 2: For the subset of patients who have chest CT, to determine the sensitivity and specificity for bilateral opacities of both chest radiographs and chest ultrasound done within 12 hours as compared to the reference standard CT scans.
As a part of the research study, we will perform a pilot study with the specific aim of assessing feasibility of a multicenter study. Criteria that will be used to assess feasibility include:
- Number of hospitalised adult patients who fulfill Kigali or Berlin ARDS criteria over the first 7 days post-hospital admission;
- Number of hospitalised adult patients who develop hypoxemia as detected on daily screening, during the first 7 days post-hospital admission (% hypoxemic patients/new admissions);
- Proportion of recruited patients/eligible patients (see below for eligibility criteria);
- Work-load per patient (lung ultrasound scanning time; average data collection time on the first day of hypoxemia);
- Proportion of patients with CXR, CT scan and LUS available from the same +/-1 day.
All adults (≥ 18 years old) admitted to the hospital during either of two one-week study periods (winter and summer) will be screened daily for hypoxemia (defined as oxygen saturation < 90%) or use of any supplemental oxygen for a total of 7 days. For the initial feasibility phase, both in-person and electronic administrative records screening will be performed. Depending on the site and the results of the pilot phase, in the multicenter study the screening will be accomplished using electronic administrative records or in-person screening.
For any eligible patient who screens positive during the study period we will collect data as detailed in the table below:
Day 1 post-hypoxemia detection
- Demographic characteristics (year of birth, sex, height, weight)
- Admission data (type of admission - elective/emergency; transfer vs direct admission vs ED admission -; date of admission; if transfer from other hospital; ward - medicine, surgery, ICU)
- Main diagnosis/clinical presentation
- Co-morbidities
- ARDS risk factors at admission
- New or worsening symptoms within 7 days
- Institution of mechanical ventilation (invasive or non-invasive)
- Oxygenation data
- Lung Ultrasound data
- CXR and CT scans occurring up to 24 hours before onset of hypoxemia
Day 2-6 post-hypoxemia detection
- Oxygenation data
- Lung Ultrasound data
- Chest imaging
Day 7 post-hypoxemia detection
- Etiology of hypoxemia (as determined by MRP)
- New ARDS risk factors identified
- Need for ICU admission first 7 days
- Institution of mechanical ventilation first 7 days (invasive and non-invasive)
- Oxygenation data
- Lung Ultrasound data
- Structured focused lung ultrasound
- Chest imaging
Outcome data collection
- Vital status at hospital separation, censored at 90 days
- Date of hospital discharge (or death)
- ICU admission and duration of ICU stay
For any eligible patient who does not screen positive during any day of the study period (days 1-7 post hospital admission), we will collect the following data:
- Vital status at hospital separation, censored at 90 days
- Date of hospital discharge (or death)
- ICU admission and duration of ICU stay
For patients undergoing CT chest during the 7 days of data collection, we will attempt the performance of an extra lung ultrasound examination immediately before or after the CT scan
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Alberto Goffi, MD
- Phone Number: 2074 416-603-5800
- Email: alberto.goffi@uhn.ca
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5T2S8
- University Health Network
-
-
-
-
-
Torino, Italy
- Ospedale San Giovanni Bosco
-
Torino, Italy
- AOU Citta' della Salute e Della Scienza - Molinette
-
-
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02215
- Beth Israel Deaconess Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Hospital admission during the study period
- Age ≥ 18 years old
- New onset of hypoxemia (SpO2 < 90% or use of any supplemental oxygen) or, for patients on home O2 treatment, higher than baseline O2 flow needed during the first 7 days of hospitalization.
Exclusion Criteria:
- Patient in the Emergency Department but not formally admitted to the hospital
- Patient admitted in PACU
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hospital-wide incidence of ARDS
Time Frame: Up to 7 days
|
ARDS incidence will be calculated as the number of patients fulfilling ARDS (Berlin or Kigali) during the first first 7 days of hospital admission divided by the total adult hospital admissions during the study period.
|
Up to 7 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sensitivity and specificity for bilateral opacities of both chest radiographs and chest ultrasound done within 12 hours as compared to the reference standard CT scans
Time Frame: Over the first 7 days of admission
|
We will calculate the sensitivity, specificity, positive predictive value and negative predictive value of both chest radiographs and ultrasound images for bilateral opacities not due to effusion, nodule or collapse, as compared with gold standard CT scan when performed.
|
Over the first 7 days of admission
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Alberto Goffi, MD, University Health Network, Toronto
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LUS01_2018
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Respiratory Failure
-
Poitiers University HospitalRecruitingAcute Respiratory Failure | Hypoxemic Respiratory FailureFrance
-
Catholic University of the Sacred HeartFisher and Paykel HealthcareCompletedWeaning Failure | Acute Respiratory FailureFrance, Greece, Italy, Spain
-
Hemovent GmbHMAXIS Medical, LLCActive, not recruitingRespiratory Failure | Cardiac Failure | Cardio-Respiratory FailureGermany
-
Hospital Clinic of BarcelonaCompletedHypercapnic Respiratory Failure | Hypoxemic Respiratory FailureSpain
-
Efficacy Care R&D LtdMemorial Hermann Hospital; CRG Medical, Inc.UnknownShock | Shock, Septic | Respiratory Failure | Respiratory Distress Syndrome | Shock, Cardiogenic | Acute Cardiac Failure | Acute Respiratory Failure | Acute Kidney Failure | Multi Organ Failure | Respiratory Arrest | Acute Respiratory Failure With Hypoxia | Acute Respiratory Failure Requiring Reintubation | Acute... and other conditionsUnited States
-
UPECLIN HC FM Botucatu UnespUnknownExtubation Failure | Acute Respiratory Failure Post ExtubationBrazil
-
Siriraj HospitalRecruitingAcute Hypoxemic Respiratory Failure | Acute Hypercapnic Respiratory FailureThailand
-
Fisher and Paykel HealthcareCentre hospitalier de l'Université de Montréal (CHUM); Institut universitaire...Not yet recruitingAcute Hypoxemic Respiratory Failure | Acute Hypercapnic Respiratory Failure
-
Hospital Sao JoaoCompletedVentilatory Failure | Post-extubation Failure | Persistent Weaning Failure | Secretion Encumbrance | Weak CoughPortugal
-
University Hospital, AngersNot yet recruitingCardio-Respiratory FailureFrance
Clinical Trials on Estimation of hospital-wide incidence of ARDS
-
Hospices Civils de LyonRecruiting
-
University of ZurichHannover Medical School; University Hospital, BonnNot yet recruitingAcute Respiratory Distress Syndrome | Corona Virus Infection | Extracorporeal Membrane Oxygenation Complication
-
Panineeya Mahavidyalaya Institute of Dental Sciences...CompletedRheumatoid Arthritis | Chronic PeriodontitisIndia
-
Sakakibara Heart InstituteCompleted
-
M.D. Anderson Cancer CenterWithdrawnMalignant Neoplasms of Independent (Primary) Multiple Sites
-
University of Medicine and Pharmacy at Ho Chi Minh...UnknownIncidence of Delirium in Inpatient Elderly PatientsVietnam
-
NorthShore University HealthSystemCompletedResidual Neuromuscular Blockade in Elderly PatientsUnited States
-
Federico BilottaUnknownPostoperative Infection | Orthopedic Patients | Severe HyperglycemiaItaly
-
Lund UniversityLinkoeping UniversityCompleted
-
Hospices Civils de LyonCompletedSeizures | Hyponatremia | BronchiolitisFrance